Life Science Venture Capital Fund, which focuses on investments in Med-tech & Digital Health companies with visible and near-term value inflection points and a prospective holding period of 3-5 years

Company focuses on development and the commercialization of cost-effective, innovative single-use devices for mechanically ventilated patients in intensive care and anesthetics

Company was established to develop and commercialize products based on innovative technology allowing higher bioavailability of active substances, in particular carotenoids.

Optimal cardiovascular prevention with DHA omega-3 and carotenoids through intelligent delivery.

A company created for the development and commercialization of patented and clinically validated functional sweets, in particular chocolate, peanut butter, sweets like toffee, candy bars

Luxury product in black chocolate format to improve skin biochemical parameters.

New generation dark chocolate produced with a proprietary PolyFountTM fortification method, which ensures the optimal level of polyphenols (cocoa epicatechins and resveratrol) is delivered to the blood circulation.

Milk chocolate with dark chocolate benefits. It is fortified with fruit-derived polyphenols with an equivalent profile to cocoa. Clinically tested bioavailable polyphenols in a delicious milk chocolate.

A formulation that has wide-ranging effects on the metabolism and the absorption of carbohydrates, and reduces the glycaemic index of meals consumed

Company focuses on the optimization of microalgae cultivation to achieve greater production output for astaxanthin.

Company develops combinations of natural ingredients that improve the overall functioning of endothelial cells.

Company focuses on the development of new immunosuppressive peptide compounds used in dermatology and transplantology.

Company develops new anticancer compounds, in particular those targeted against brain tumours- gliomas.